These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1692992)

  • 1. Antagonism by GRP(18-27) and substance P analogues on insulin release stimulated by GRP(18-27).
    Mukai H; Kawai K; Suzuki S; Yamashita K; Munekata E
    Peptides; 1990; 11(1):173-5. PubMed ID: 1692992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ala6]gastrin-releasing peptide-10: an analogue with dissociated biological activities.
    Mukai H; Kawai K; Suzuki S; Ohmori H; Yamashita K; Munekata E
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E235-40. PubMed ID: 2669516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.
    Woll PJ; Rozengurt E
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1859-63. PubMed ID: 2450349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats.
    Pinski J; Yano T; Groot K; Cai RZ; Radulovic S; Schally AV
    Am J Physiol; 1992 Oct; 263(4 Pt 1):E712-7. PubMed ID: 1415689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of bombesin-stimulated gastrin release from isolated canine G cells by bombesin antagonists.
    Campos RV; Buchan AM; Pederson RA; McIntosh CH; Coy DH
    Can J Physiol Pharmacol; 1989 Dec; 67(12):1520-4. PubMed ID: 2483358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neuromedin B, gastrin-releasing peptide-10 and their fragment peptides on secretion of gastrointestinal and pancreatic hormones in dogs.
    Kawai K; Chiba Y; Mukai H; Munekata E; Yamashita K
    Acta Endocrinol (Copenh); 1988 Feb; 117(2):205-13. PubMed ID: 3289296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neuromedin B and neuromedin C on exocrine and endocrine rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Tani S; Oka T; Yajima H; Baba S
    Am J Physiol; 1987 Apr; 252(4 Pt 1):G491-8. PubMed ID: 2436486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of gastrin-releasing peptide on the endocrine pancreas.
    McDonald TJ; Houghton P; Challis JR; Hramiak IM
    Ann N Y Acad Sci; 1988; 547():242-54. PubMed ID: 3071222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of inositol lipid hydrolysis in human breast cancer cells by two classes of bombesin antagonist.
    Patel KV; Schrey MP
    J Mol Endocrinol; 1991 Feb; 6(1):71-8. PubMed ID: 1707628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of ability of various substance P antagonists to inhibit action of bombesin.
    Jensen RT; Heinz-Erian P; Mantey S; Jones SW; Gardner JD
    Am J Physiol; 1988 Jun; 254(6 Pt 1):G883-90. PubMed ID: 2454035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of substance P antagonists with substance P receptors on dispersed pancreatic acini.
    Jensen RT; Jones SW; Lu YA; Xu JC; Folkers K; Gardner JD
    Biochim Biophys Acta; 1984 Jun; 804(2):181-91. PubMed ID: 6202326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [D-Arg1,D-Trp5,7,9,Leu11]Substance P coordinately and reversibly inhibits bombesin- and vasopressin-induced signal transduction pathways in Swiss 3T3 cells.
    Seckl MJ; Higgins T; Rozengurt E
    J Biol Chem; 1996 Nov; 271(46):29453-60. PubMed ID: 8910612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of neuromedin B on insulin and glucagon release from the isolated perfused rat pancreas.
    Kawai K; Mukai H; Chiba Y; Ohmori H; Suzuki S; Munekata E; Yamashita K
    Endocrinol Jpn; 1989 Aug; 36(4):587-94. PubMed ID: 2684623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of slow excitatory post-synaptic potential by substance P antagonists in guinea-pig sympathetic ganglia.
    Konishi S; Otsuka M
    J Physiol; 1985 Apr; 361():115-30. PubMed ID: 2580973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bombesin stimulates the release of insulin and glucagon, but not pancreatic somatostatin, from the isolated perfused dog pancreas.
    Ipp E; Unger RH
    Endocr Res Commun; 1979; 6(1):37-42. PubMed ID: 385299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of gastrin-releasing peptide on the endocrine pancreas.
    Knuhtsen S; Holst JJ; Schwartz TW; Jensen SL; Nielsen OV
    Regul Pept; 1987 May; 17(5):269-76. PubMed ID: 2885899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrin-releasing peptide directly releases pepsinogen from guinea pig chief cells.
    Fiorucci S; McArthur KE
    Am J Physiol; 1990 Nov; 259(5 Pt 1):G760-6. PubMed ID: 1700625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the substance P antagonist, (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP on the miotic response to substance P, antidromic trigeminal nerve stimulation, capsaicin, prostaglandin E1, compound 48/80 and histamine.
    Mandahl A; Bill A
    Acta Physiol Scand; 1984 Jan; 120(1):27-35. PubMed ID: 6202097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of bombesin receptors on isolated muscle cells from human intestine.
    Micheletti R; Grider JR; Makhlouf GM
    Regul Pept; 1988 Jun; 21(3-4):219-26. PubMed ID: 2842822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.